{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T15:50:42Z","timestamp":1719157842762},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T00:00:00Z","timestamp":1421193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s12094-014-1271-x","type":"journal-article","created":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T06:21:28Z","timestamp":1421130088000},"page":"576-580","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Two novel frameshift mutations in BRCA2 gene detected by next generation sequencing in a survey of Spanish patients of breast cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"I.","family":"Hernan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ma\u00f1\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Borr\u00e0s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"de Sousa Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Llort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Yag\u00fce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Gamundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c0.","family":"Arcusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Carballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,14]]},"reference":[{"key":"1271_CR1","first-page":"692","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Link Consort Lancet. 1994;343:692\u20135.","journal-title":"Breast Cancer Link Consort Lancet"},{"key":"1271_CR2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"The breast cancer linkage consortium","year":"1999","unstructured":"The breast cancer linkage consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91:1310\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"1271_CR3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643\u20136.","journal-title":"Science"},{"key":"1271_CR4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","volume":"91","author":"J Peto","year":"1999","unstructured":"Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 1999;91:943\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"1271_CR5","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/93.16.1215","volume":"93","author":"N Loman","year":"2001","unstructured":"Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst. 2001;93:1215\u201323.","journal-title":"J Natl Cancer Inst"},{"key":"1271_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0959-437X(96)90017-9","volume":"6","author":"MR Stratton","year":"1996","unstructured":"Stratton MR, Wooster R. Hereditary predisposition to breast cancer. Curr Opin Genet Dev. 1996;6:93\u20137.","journal-title":"Curr Opin Genet Dev"},{"key":"1271_CR7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.genet.32.1.95","volume":"32","author":"N Rahman","year":"1998","unstructured":"Rahman N, Stratton MR. The genetics of breast cancer susceptibility. Annu Rev Genet. 1998;32:95\u2013121.","journal-title":"Annu Rev Genet"},{"key":"1271_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/humu.10260","volume":"22","author":"O D\u00edez","year":"2003","unstructured":"D\u00edez O, Osorio A, Dur\u00e1n M, Martinez-Ferrandis JI, de la Hoya M, Salazar R, et al. Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat. 2003;22:301\u201312.","journal-title":"Hum Mutat"},{"key":"1271_CR9","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","volume":"16","author":"TS Frank","year":"1998","unstructured":"Frank TS, Manley SA, Olopade OI, Cummings S, Garber JE, Bernhardt B, et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 1998;16:2417\u201325.","journal-title":"J Clin Oncol"},{"key":"1271_CR10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.ejhg.5201806","volume":"15","author":"A Gerhardus","year":"2007","unstructured":"Gerhardus A, Schleberger H, Schlegelberger B, Gadzicki D. Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. Eur J Hum Genet. 2007;15:619\u201327.","journal-title":"Eur J Hum Genet"},{"key":"1271_CR11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jmoldx.2012.06.003","volume":"14","author":"M Chan","year":"2012","unstructured":"Chan M, Ji SM, Yeo ZX, Gan L, Yap E, Yap YS, et al. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. J Mol Diagn. 2012;14:602\u201312.","journal-title":"J Mol Diagn"},{"key":"1271_CR12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jmoldx.2012.01.013","volume":"14","author":"I Hernan","year":"2012","unstructured":"Hernan I, Borr\u00e0s E, de Sousa Dias M, Gamundi MJ, Ma\u00f1\u00e9 B, Llort G, et al. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing. J Mol Diagn. 2012;14:286\u201393.","journal-title":"J Mol Diagn"},{"key":"1271_CR13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jmoldx.2012.05.006","volume":"14","author":"G Michils","year":"2012","unstructured":"Michils G, Hollants S, Dehaspe L, Van Houdt J, Bidet Y, Uhrhammer N, et al. Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing. J Mol Diagn. 2012;14:623\u201330.","journal-title":"J Mol Diagn"},{"key":"1271_CR14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ejhg.2012.270","volume":"21","author":"L Feliubadal\u00f3","year":"2013","unstructured":"Feliubadal\u00f3 L, Lopez-Doriga A, Castellsagu\u00e9 E, del Valle J, Men\u00e9ndez M, Tornero E, et al. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. Eur J Hum Genet. 2013;21:864\u201370.","journal-title":"Eur J Hum Genet"},{"key":"1271_CR15","doi-asserted-by":"crossref","first-page":"e25531","DOI":"10.1371\/journal.pone.0025531","volume":"6","author":"K Leeneer De","year":"2011","unstructured":"De Leeneer K, De Schrijver J, Clement L, Baetens M, Lefever S, De Keulenaer S, et al. Practical tools to implement massive parallel pyrosequencing of PCR prod-ucts in next generation molecular diagnostics. PLoS One. 2011;6:e25531.","journal-title":"PLoS One"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1271-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-014-1271-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1271-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T12:49:14Z","timestamp":1566218954000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-014-1271-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,14]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1007\/s12094-014-1271-x","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,14]]}}}